Carl Zeiss Meditec (ETR:AFX) Shares Down 1.3% – Here’s What Happened

Carl Zeiss Meditec AG (ETR:AFX)’s stock price was down 1.3% during trading on Monday . The company traded as low as €25.04 and last traded at €25.04. Approximately 186,111 shares were traded during trading, an increase of 97% from the average daily volume of 94,405 shares. The stock had previously closed at €25.38.

Carl Zeiss Meditec Stock Performance

The company has a quick ratio of 2.47, a current ratio of 2.35 and a debt-to-equity ratio of 28.70. The firm has a 50-day moving average price of €31.72 and a 200 day moving average price of €39.23. The firm has a market capitalization of $2.33 billion, a PE ratio of 13.38, a price-to-earnings-growth ratio of 2.83 and a beta of 1.44.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.